Religem 200mg Injection
Marketer
Relic Biotechnology Pvt Ltd
Salt Composition
Gemcitabine (200mg)
Overview Religem 200mg Injection
Oncaspar 200mg Injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdosage can lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can decrease blood cell counts, increasing infection risk, necessitating regular blood tests monitoring blood cell levels, cardiac function, liver health, and uric acid. Inform your physician of pre-existing heart, liver, or kidney conditions, and all other medications, especially anti-infectives, as drug interactions are possible. It's contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Primary Ingredients of Religem 200mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Religem 200mg Injection
Lung, breast, pancreatic, bladder, and ovarian cancers (excluding small cell lung cancer).
Major Benefits of Religem 200mg Injection:
Administering this medication requires the supervision of your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Religem 200mg Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Religem 200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Religem 200mg Injection works:
Religem 200mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential components, thus inhibiting their growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Religem 200mg Injection and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Religem 200mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingUNSAFE
Administering Religem 200mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Religem 200mg Injection may induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Religem 200mg Injection's use in individuals with impaired renal function. Physician consultation is necessary. Assessment of kidney function is recommended prior to and during treatment with this medication.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Religem 200mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Religem 200mg Injection :
NA
Facts to Know About Religem 200mg Injection
| Label | Value |
|---|---|
| Chemical Category | Modified Cytosine |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic inhibitors |
3,018 People bought this recently